243 related articles for article (PubMed ID: 19050584)
1. Identifying mechanisms for therapeutic intervention in chordoma: c-Met oncoprotein.
Ostroumov E; Hunter CJ
Spine (Phila Pa 1976); 2008 Dec; 33(25):2774-80. PubMed ID: 19050584
[TBL] [Abstract][Full Text] [Related]
2. Expression of hepatocyte growth factor and c-MET in skull base chordoma.
Naka T; Kuester D; Boltze C; Scheil-Bertram S; Samii A; Herold C; Ostertag H; Krueger S; Roessner A
Cancer; 2008 Jan; 112(1):104-10. PubMed ID: 17948912
[TBL] [Abstract][Full Text] [Related]
3. Expression of c-MET, low-molecular-weight cytokeratin, matrix metalloproteinases-1 and -2 in spinal chordoma.
Naka T; Boltze C; Samii A; Samii M; Herold C; Ostertag H; Iwamoto Y; Oda Y; Tsuneyoshi M; Kuester D; Roessner A
Histopathology; 2009 Apr; 54(5):607-13. PubMed ID: 19302530
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor function and c-Met expression in human lens epithelial cells.
Wormstone IM; Tamiya S; Marcantonio JM; Reddan JR
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4216-22. PubMed ID: 11095618
[TBL] [Abstract][Full Text] [Related]
5. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
Kim CH; Kim J; Kahng H; Choi EC
Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
[TBL] [Abstract][Full Text] [Related]
6. The role of extracellular factors in human metastatic chordoma cell growth in vitro.
Ostroumov E; Hunter CJ
Spine (Phila Pa 1976); 2007 Dec; 32(26):2957-64. PubMed ID: 18091487
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor (HGF) and receptor (c-met) in normal and malignant astrocytic cells.
Welch WC; Kornblith PL; Michalopoulos GK; Petersen BE; Beedle A; Gollin SM; Goldfarb RH
Anticancer Res; 1999; 19(3A):1635-40. PubMed ID: 10470094
[TBL] [Abstract][Full Text] [Related]
8. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.
Burgess T; Coxon A; Meyer S; Sun J; Rex K; Tsuruda T; Chen Q; Ho SY; Li L; Kaufman S; McDorman K; Cattley RC; Sun J; Elliott G; Zhang K; Feng X; Jia XC; Green L; Radinsky R; Kendall R
Cancer Res; 2006 Feb; 66(3):1721-9. PubMed ID: 16452232
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies.
Weinberger PM; Yu Z; Kowalski D; Joe J; Manger P; Psyrri A; Sasaki CT
Arch Otolaryngol Head Neck Surg; 2005 Aug; 131(8):707-11. PubMed ID: 16103303
[TBL] [Abstract][Full Text] [Related]
10. Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines.
Watanabe T; Tsuda M; Makino Y; Ichihara S; Sawa H; Minami A; Mochizuki N; Nagashima K; Tanaka S
Mol Cancer Res; 2006 Jul; 4(7):499-510. PubMed ID: 16849525
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of SMYD3 by RNA interference down-regulates c-Met expression and inhibits cells migration and invasion induced by HGF.
Zou JN; Wang SZ; Yang JS; Luo XG; Xie JH; Xi T
Cancer Lett; 2009 Jul; 280(1):78-85. PubMed ID: 19321255
[TBL] [Abstract][Full Text] [Related]
12. Expression and functional role of hepatocyte growth factor and its receptor (c-met) during fetal mouse testis development.
Ricci G; Catizone A; Galdieri M
J Endocrinol; 2006 Dec; 191(3):559-70. PubMed ID: 17170214
[TBL] [Abstract][Full Text] [Related]
13. c-Met activation in medulloblastoma induces tissue factor expression and activity: effects on cell migration.
Provençal M; Labbé D; Veitch R; Boivin D; Rivard GE; Sartelet H; Robitaille Y; Gingras D; Béliveau R
Carcinogenesis; 2009 Jul; 30(7):1089-96. PubMed ID: 19359592
[TBL] [Abstract][Full Text] [Related]
14. c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.
Christensen JG; Burrows J; Salgia R
Cancer Lett; 2005 Jul; 225(1):1-26. PubMed ID: 15922853
[TBL] [Abstract][Full Text] [Related]
15. Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization.
Yang H; Zhu L; Ebraheim NA; Liu X; Castillo S; Tang T; Liu J; Cui H
Spine J; 2009 Dec; 9(12):972-80. PubMed ID: 19800296
[TBL] [Abstract][Full Text] [Related]
16. Autocrine and/or paracrine growth of aggressive ATLL cells caused by HGF and c-Met.
Onimaru Y; Tsukasaki K; Murata K; Imaizumi Y; Choi YL; Hasegawa H; Sugahara K; Yamada Y; Hayashi T; Nakashima M; Taguchi T; Mano H; Kamihira S; Tomonaga M
Int J Oncol; 2008 Oct; 33(4):697-703. PubMed ID: 18813782
[TBL] [Abstract][Full Text] [Related]
17. Noncompetitive inhibition of hepatocyte growth factor-dependent Met signaling by a phage-derived peptide.
Tam EM; Runyon ST; Santell L; Quan C; Yao X; Kirchhofer D; Skelton NJ; Lazarus RA
J Mol Biol; 2009 Jan; 385(1):79-90. PubMed ID: 18973760
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
Matsumoto K; Nakamura T; Sakai K; Nakamura T
Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
[TBL] [Abstract][Full Text] [Related]
19. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
Tiran Z; Oren A; Hermesh C; Rotman G; Levine Z; Amitai H; Handelsman T; Beiman M; Chen A; Landesman-Milo D; Dassa L; Peres Y; Koifman C; Glezer S; Vidal-Finkelstein R; Bahat K; Pergam T; Israel C; Horev J; Tsarfaty I; Ayalon-Soffer M
Clin Cancer Res; 2008 Jul; 14(14):4612-21. PubMed ID: 18628476
[TBL] [Abstract][Full Text] [Related]
20. Presence and tyrosine phosphorylation of c-met receptor in human sperm.
Herness EA; Naz RK
J Androl; 1999; 20(5):640-7. PubMed ID: 10520577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]